Conference on 6th Annual Drug Delivery Systems

Conference on 6th Annual Drug
Delivery Systems
Moving towards effective drug
delivery technologies and deal making
1st - 2nd February 2011, BSG
Conference Centre, London, UK
Key Speakers:
Dr. Sven Stegemann, Director,
Dr. Sophie Van Tomme, Pharmaceutical Scientist, Abbott
Gerrit Hauck, Head PSD R&D Operations, Sanofi -Aventis
Matthew Roe, Senior Director-Business Development and Licensing, Genzyme
Dr. Oliver Steinbach, Department Head, Philips Research Laboratories
Dr. Rajan K. Verma, Senior Manager Early Development Formulations – Generics
Integrated Product Development (IPDO), Dr Reddy’s Laboratories
Dr. Deirdre McIntosh, Director, McIntosh Scientific Advice Services
Dr. Michel Deleers, CEO, OncoBel
Dr. Andrew Lewis, Operations Director, Critical Pharmaceuticals
Dr. Ben Forbes, Senior Lecturer in Pharmaceutics, King’s College, London
Ketan Pancholi, Lecturer, The Robert Gordon University
Gerry Kamstra Partner, IP & Life Sciences, Bird and Bird
Conference Introduction
Shrinking global capital
markets, new healthcare policies, ageing populations, the growth of emerging
economies, technological advances and the advent of regenerative and biological
medicines are just some of the factors expected to shape the future drug
delivery device market. (Source: Cambridge Consultants UK, September 2009)
With increased competition and
the growing importance of patience compliance, pharmaceutical companies are
working towards developing effective and targeted drug
delivery systems, to transform disease treatments. Now in its 6th year, Drug
Delivery Systems Conference showcases the basics and latest developments for
inhaled drug, RNAi based therapies and protein and peptide methods. We have put
together an unparalleled scientific programme comprising insightful
presentations by leading experts from Pfizer, Philips Research, Dr Reddy’s
Laboratories and Genzyme. This conference will feature keynote addresses, case
studies and interactive discussions
ranging from current and evolving drug delivery technologies to advancement and
manufacturing of more efficient formulations.
Attendance at this conference
will enable you to:

  • Benefit from thorough updates of recent developments in the drug delivery

  • Examine challenges in generic development of drug delivery systems

  • Learn from in-depth case study from Philips about image-guided
    ultrasound-mediated drug delivery

  • Identify different strategies in managing a drug delivery alliance

  • Know how to overcome the industry challenges for inhaled delivery systems

  • Discuss key regulatory and legal issues

  • Recognise the importance of new biologic delivery technologies

  • Discuss microbubble production technologies and its effect on delivery

  • Create patient centered drug delivery product

  • Network with experts and opinion leaders from pharma, biotech, device and
    drug delivery industries

Who should attend?
VPs, Directors, Heads,
Managers of:

  • Drug Delivery

  • Preformulation /Formulation/Stability

  • Business Development

  • Licensing

  • Technology Assessment

  • Commercial Development

  • Patents

  • Lifecycle Management

  • Strategic Planning and Development

  • Financial Analyst

  • Pharmaceutical and Analytical R&D

  • Pharmaceutical Science

  • Testing

  • Product Development

  • New Product Planning]

  • New Technology Evaluation

  • Marketing

  • Brand Management

  • Product Management

  • Sales

  • Regulatory Affairs


  • Intellectual Property Attorneys

  • Venture Capitalists

  • Medical Device Companies

  • Analysts/Investment Banks


  • Contract Sales Organisations

  • Universities and Government Research

  • Testing and Manufacturing Equipment

  • Packaging Companies

    For more information please visit to